Plain-English translation of NCT07426718 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing a device called Inflammacheck® that measures markers of inflammation in your breath to see if it can help identify lung cancer. This study will compare breath samples from healthy people, people with confirmed lung cancer, people suspected of having lung cancer, and people with pneumonia to see if the breath test can accurately tell these conditions apart.
Lung cancer is often diagnosed late, and current screening methods miss many cases, especially in women and non-smokers. There is no simple, quick, non-invasive test to help doctors decide which patients with respiratory symptoms need further investigation for lung cancer—and this study aims to fill that gap.
You likely qualify if…
You likely don't qualify if…
You will visit the research site and provide a breath sample using the Inflammacheck® device—a simple, non-invasive test that takes just a few minutes. The researchers will also review your medical records and any imaging results to understand your health status. Depending on which group you are in (healthy, confirmed lung cancer, suspected lung cancer, or pneumonia), your visit may be a one-time appointment.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
United Kingdom